Bionano Senior Management Team Member, President and CEO Erik Holmlin, PhD
Erik Holmlin, PhD
President and Chief Executive Officer

Erik Holmlin is a dynamic leader with more than two decades of experience developing innovative solutions and companies in the life sciences and health care industries.

Read More

Erik’s experience includes positions at GenVault Corporation (CEO), Exiqon A/S (CCO) and Becton Dickinson (vice president of marketing and development). In 2001, Erik led the formation and financing efforts of GeneOhm Sciences, Inc. and orchestrated the company’s acquisition by Becton Dickinson in 2006. He also served as an entrepreneur in residence (EIR) at leading life-science venture capital firm Domain Associates, LLC.

Erik was a National Institutes of Health postdoctoral fellow at Harvard University and a National Science Foundation predoctoral fellow at the California Institute of Technology, Pasadena (Caltech). He holds a PhD in chemistry from Caltech and MBAs from UC Berkeley and Columbia University.

Read Less
Bionano Senior Management Team Member, Founder and CSO, Han Cao, PhS
Han Cao, PhD
Founder and Chief Scientific Officer

Han Cao founded Bionano Genomics in 2003 as a spinoff of the Princeton University laboratories, where he was working on a multimillion-dollar project funded by the U.S. Defense Advanced Research Projects Agency (DARPA).

Read More

Dr. Cao is the key co-inventor of the company’s core single-molecule nanoscale whole genome analysis technology. Prior to that, he was a postdoctoral fellow working on a stem cell and DNA repair system at the Institute for Human Gene Therapy of University of Pennsylvania Medical Center. His diverse experience includes molecular biology, microarray and genomics technology development, and single-molecule analysis, as well as micro and nanofluidics design and fabrication.

Dr. Cao leads multiple federal government-funded projects at Bionano and has served on many grant review panels. He oversees the scientific and technical direction of future technology and product development at Bionano. Dr. Cao received his bachelor’s degree from the University of Science and Technology of China and his PhD in molecular biology from the University of Delaware.

Read Less
Bionano Senior Management Team Member, VP, Corporate Development, Mike Ward
Mike Ward
Vice President, Corporate Development

Mike Ward has more than 20 years of experience in life sciences-dedicated investment banking, venture capital and private equity investments.

Read More

Before joining Bionano Genomics, Mike was at Lurie Investment Fund, where he was responsible for managing the life sciences venture capital and private equity investments of the Lurie family. Mike guided senior management teams of Lurie’s life sciences portfolio companies in conducting business and corporate development, clinical and regulatory strategy, commercialization planning, intellectual property management, M&A, and financings. During his tenure, Mike also served on the boards of a number of life sciences portfolio companies on behalf of Lurie.

Prior to joining Lurie Investment Fund, Mike gained more than 15 years of investment banking experience at Leerink Partners, Credit Suisse, Dresdner Kleinwort Wasserstein, BMO and Vector Securities. During his career in investment banking, Mike executed more than 80 life sciences mergers, acquisitions, divestitures, strategic alliances, private placements, IPOs and follow-on public offerings. In his more than two decades of experience serving and fostering life sciences companies, Mike has focused predominantly on the medical technology, tools, diagnostics and biopharmaceutical markets. Mike received, with summa cum laude distinction, a bachelor’s in finance from the University of Illinois.

Read Less
Bionano Senior Management Team Member, VP, Systems Development, Mark Borodkin
Mark Borodkin
Vice President, Systems Development

Mark Borodkin has a 20-year history of success in the development of systems for the life sciences and medical device industries.

Read More

Prior to joining Bionano Genomics, Mark led a global team at Brooks Life Science Systems in the development of sample analyzers, high-throughput screening solutions, and chemical storage and biobank systems. Prior to his time at Brooks, Mark was with Affymetrix, where he launched the array platform that is widely used today for GWAS and other genomics applications. Mark also spent time at Siemens Healthcare Diagnostics on the development of equipment for diagnostic core labs. During his 13 years at Life Technologies (formerly Applied Biosystems) he held various levels of responsibility in the development of systems for real-time PCR, sequencing and sample preparation. Mark holds a bachelor’s degree in electrical engineering and a master’s degree in computer and systems engineering from Rensselaer Polytechnic Institute in New York.

Read Less

Discover what’s missing in your research

Let's talk